Atossa Therapeutics Inc
NASDAQ:ATOS
Atossa Therapeutics Inc
NASDAQ:ATOS
Price:
5.42
USD
-1.63%
Market Cap:
$46.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Atossa Therapeutics Inc
NASDAQ:ATOS
|
US |
|
Nagaoka International Corp
TSE:6239
|
JP |
|
W
|
Westwing Comercio Varejista SA
BOVESPA:WEST3
|
BR |
|
Is Yatirim Menkul Degerler AS
IST:ISMEN.E
|
TR |
|
I
|
InspireMD Inc
XBER:II2
|
IL |
|
D
|
Delta Giri Wacana Tbk PT
IDX:DGWG
|
ID |
|
Edenville Energy PLC
LSE:EDL
|
UK |
Balance Sheet
Balance Sheet Decomposition
Atossa Therapeutics Inc
Atossa Therapeutics Inc
Balance Sheet Decomposition is not available for
Atossa Therapeutics Inc
Atossa Therapeutics Inc
Balance Sheet
Atossa Therapeutics Inc
Atossa Therapeutics Inc
Currency: USD
| Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
2
|
2
|
6
|
9
|
4
|
3
|
7
|
10
|
13
|
40
|
136
|
111
|
88
|
71
|
|
| Cash Equivalents |
0
|
0
|
2
|
2
|
6
|
9
|
4
|
3
|
7
|
10
|
13
|
40
|
136
|
111
|
88
|
71
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
3
|
4
|
7
|
4
|
3
|
|
| Total Current Assets |
0
|
0
|
3
|
2
|
7
|
9
|
4
|
3
|
8
|
12
|
14
|
43
|
141
|
118
|
92
|
74
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
5
|
4
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
2
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
|
| Total Assets |
0
N/A
|
0
N/A
|
3
N/A
|
7
+119%
|
12
+76%
|
12
-2%
|
6
-47%
|
4
-34%
|
8
+100%
|
12
+43%
|
15
+24%
|
43
+195%
|
141
+230%
|
124
-13%
|
96
-22%
|
76
-21%
|
|
| Liabilities | |||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
1
|
1
|
|
| Accrued Liabilities |
0
|
1
|
0
|
2
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
3
|
3
|
|
| Short-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
13
|
0
|
0
|
2
|
2
|
|
| Total Current Liabilities |
0
|
1
|
2
|
2
|
1
|
2
|
3
|
1
|
1
|
3
|
1
|
16
|
3
|
6
|
5
|
5
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+800%
|
2
+67%
|
2
+13%
|
1
-18%
|
2
+64%
|
3
+9%
|
1
-60%
|
1
+20%
|
3
+142%
|
1
-55%
|
16
+1 108%
|
3
-80%
|
6
+81%
|
5
-7%
|
5
-5%
|
|
| Equity | |||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
2
|
9
|
23
|
23
|
23
|
23
|
|
| Retained Earnings |
0
|
1
|
5
|
10
|
21
|
35
|
51
|
57
|
65
|
77
|
94
|
112
|
129
|
156
|
186
|
212
|
|
| Additional Paid In Capital |
0
|
0
|
6
|
15
|
31
|
45
|
55
|
60
|
72
|
82
|
105
|
130
|
244
|
251
|
256
|
261
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Equity |
0
N/A
|
1
N/A
|
2
N/A
|
5
+225%
|
11
+104%
|
10
-10%
|
4
-61%
|
3
-16%
|
7
+123%
|
9
+28%
|
13
+50%
|
27
+106%
|
138
+408%
|
118
-15%
|
91
-23%
|
71
-21%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
3
N/A
|
7
+119%
|
12
+76%
|
12
-2%
|
6
-47%
|
4
-34%
|
8
+100%
|
12
+43%
|
15
+24%
|
43
+195%
|
141
+230%
|
124
-13%
|
96
-22%
|
76
-21%
|
|
| Shares Outstanding | |||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
8
|
8
|
8
|
9
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
